| Literature DB >> 27187335 |
Li-Jun Zhou1,2, Fu-Rong Li3, Li-Jie Huang4, Zhi-Rong Yang5, Shu Yuan6, Lin-Han Bai7.
Abstract
Eucalyptus oil possesses a wide spectrum of biological activity, including anti-microbial, fungicidal, herbicidal, acaricidal and nematicidal properties. We studied anti-fungal activities of the leaf oil extracted from Eucalyptus. grandis × E. urophylla. Eleven plant pathogenic fungi were tested based on the mycelium growth rates with negative control. The results showed that Eucalyptus oil has broad-spectrum inhibitory effects toward these fungi. Remarkable morphological and structural alterations of hypha have been observed for Magnaporthe grisea after the treatment. The mRNA genome array of M. grisea was used to detect genes that were differentially expressed in the test strains treated by the Eucalyptus oil than the normal strains. The results showed 1919 genes were significantly affected, among which 1109 were down-regulated and 810 were up-regulated (p < 0.05, absolute fold change >2). According to gene ontology annotation analysis, these differentially expressed genes may cause abnormal structures and physiological function disorders, which may reduce the fungus growth. These results show the oil has potential for use in the biological control of plant disease as a green biopesticide.Entities:
Keywords: E. grandis × E. urophylla oil; M. grisea; antifungal effects; biological control; mRNA Genome Array
Mesh:
Substances:
Year: 2016 PMID: 27187335 PMCID: PMC6273397 DOI: 10.3390/molecules21050621
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Inhibitory activities of the Eucalyptus oil on plant pathogenic fungi.
| Strain | Control Group (cm) | EO-Treated Group (cm) | Inhibition Rate (%) |
|---|---|---|---|
| 1.7 ± 0.3 | 0.6 ± 0.2 | 91 ± 9 | |
| 2.4 ± 0.4 | 1.5 ± 0.3 | 81 ± 7 | |
| 3.0 ± 0.8 | 1.1 ± 0.3 | 75 ± 7 | |
| 5.2 ± 1.7 | 1.7 ± 0.4 | 74 ± 6 | |
| 5.9 ± 1.6 | 2.6 ± 0.6 | 62 ± 6 | |
| 5.4 ± 1.5 | 2.6 ± 0.8 | 56 ± 5 | |
| 3.5 ± 1.0 | 2.1 ± 0.5 | 46 ± 5 | |
| 2.9 ± 0.6 | 2.0 ± 0.4 | 45 ± 5 | |
| 4.0 ± 1.1 | 2.9 ± 0.7 | 31 ± 5 | |
| 3.6 ± 1.0 | 2.8 ± 0.7 | 26 ± 4 | |
| 4.3 ± 1.1 | 3.3 ± 0.7 | 25 ± 4 |
Diameters of the plaques and inhibition rates (determined by the mycelium growth rate method) are shown.
Figure 1The oil impact on the growth of M. grisea after being cultured for 5 days and 7 days.
Figure 2Eucalyptus oil effects on M. grisea hypha growth by the scanning electron microscopy. (A) control group; (B) experimental group.
Figure 3The tests for the hybridization process. RNA integrity (A) was assessed by standard denaturing agarose gel electrophoresis. Scatter plots (B) shows the correlation of signal values between control group and experimental group. The box diagram (C) shows the results of data processing and normalization (to the actin 1 gene). RT-PCR (D) shows a similar expression pattern to the corresponding results of gene chip. The up-regulated gene is peroxisomal membrane protein 4 (PXMP4); the down-regulated gene is alcohol dehydrogenase (ADH). Bars indicate SD.
GO analysis for differentially expressed genes.
| GO Terms | Terms Type | Genes_In_Term | DEG | Up | Down | |
|---|---|---|---|---|---|---|
| GO:0055114 (oxidation-reduction process) | P | 777 | 109 | 51 | 58 | 1.53 × 10−10 |
| GO:0044271 (cellular nitrogen compound biosynthetic process) | P | 38 | 14 | 0 | 14 | 1.01 × 10−5 |
| GO:0043581 (mycelium development) | P | 468 | 59 | 22 | 37 | 5.60 × 10−4 |
| GO:0009103 (lipopolysaccharide biosynthetic process) | P | 10 | 6 | 4 | 2 | 6.24 × 10−4 |
| GO:0006066 (alcohol metabolic process) | P | 13 | 6 | 4 | 2 | 3.37 × 10−3 |
| GO:0055085 (transmembrane transport) | P | 292 | 37 | 10 | 27 | 1.06 × 10−2 |
| GO:0052051 (interaction with host via protein secreted by type II secretion system) | P | 50 | 11 | 9 | 2 | 1.15 × 10−2 |
| GO:0008152 (metabolic process) | P | 328 | 39 | 27 | 12 | 1.69 × 10−2 |
| GO:0005375 (copper ion transmembrane transporter activity) | P | 8 | 4 | 1 | 3 | 1.69 × 10−2 |
| GO:0035434 (copper ion transmembrane transport) | P | 8 | 4 | 1 | 3 | 1.69 × 10−2 |
| Total P | 1992 | 289 | 129 | 160 | ||
| GO: 0016491 (oxidoreductase activity) | F | 268 | 50 | 23 | 27 | 6.79 × 10−9 |
| GO:0050660 (flavin adenine dinucleotide binding) | F | 90 | 18 | 11 | 7 | 2.27 × 10−3 |
| GO:0008812 (choline dehydrogenase activity) | F | 9 | 5 | 3 | 2 | 6.47 × 10−3 |
| GO:0004181 (metallocarboxypeptidase activity) | F | 6 | 4 | 1 | 3 | 9.44 × 10−3 |
| GO:0003824 (catalytic activity) | F | 175 | 24 | 11 | 13 | 2.44 × 10−2 |
| GO:0000981 (sequence-specific DNA binding RNA polymerase II transcription) factor activity) | F | 113 | 17 | 11 | 6 | 3.99 × 10−2 |
| Total F | 661 | 118 | 60 | 58 | ||
| GO:0016021 (integral to membrane) | C | 742 | 52 | 21 | 31 | 3.37 × 10−6 |
| GO:0005737 (cytoplasm) | C | 259 | 20 | 1 | 19 | 8.13 × 10−3 |
| GO:0005634 (nucleus) | C | 610 | 35 | 18 | 17 | 1.41 × 10−2 |
| Total C | 1611 | 107 | 40 | 67 |
DEG = differentially expressed genes; P: biological_process; C: cellular_component; F: molecular_function.